Simple Summary Talimogene laherparepvec (T-VEC; IMLYGIC®, Amgen Inc.) is the first
oncolytic viral immunotherapy to be approved for the local treatment of unresectable …

Introduction: The eighth edition of the American Joint Committee on Cancer (AJCC)
melanoma staging system was implemented in the United States on 1 January 2018. Areas …

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been
expanded to include pathways for treatment of microscopic satellitosis (added in v2. 2020) …

Answer questions and earn CME/CNE To update the melanoma staging system of the
American Joint Committee on Cancer (AJCC) a large database was assembled comprising> …

Melanoma often spreads to cutaneous or subcutaneous sites that are amenable to direct,
intralesional injection. As such, develo** effective injectable agents has been of …

Cutaneous melanoma (CM) encompasses a group of pigmented tumors that arise from skin
melanocytes. Melanocytes are neural crest-derived cells that commonly migrate to the skin …

Patients with cutaneous melanoma can develop in-transit metastases (ITM), most often
localized to limbs. For patients with uveal melanoma that develop metastatic disease, the …

Melanoma is one of the deadliest skin tumors, accounting for almost 90% of skin cancer
mortality. Although immune therapy and targeted therapy have dramatically changed the …

Strides in melanoma surveillance, detection, and treatment continue to be made. The
American Joint Committee on Cancer Eighth Edition Cancer Staging System has improved …

Background Little is known about outcomes of adjuvant-treated melanoma patients beyond
the clinical trial setting. Since 2019, adjuvant-treated melanoma patients have been …